Occupational lead exposure and screening of glucose-6-phosphate dehydrogenase polymorphism: Useful prevention or nonvoluntary discrimination?

International Archives of Occupational and Environmental Health

Volumn 71, Issue 2, 1998, Pages 148-150

  Cocco, Pierluigi ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Epidemiology; Glucose 6 phosphate dehydrogenase deficiency; Industrial toxicology; Lead; Regulatory guidelines

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; LEAD;

ARTICLE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; ENZYME POLYMORPHISM; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; ISCHEMIC HEART DISEASE; ITALY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; PHENOTYPE; SMELTER;

ADOLESCENT; ADULT; AGED; ELIGIBILITY DETERMINATION; EMPLOYMENT; EPIDEMIOLOGIC STUDIES; FINLAND; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; HYPERSENSITIVITY; LEAD; MALE; MASS SCREENING; MIDDLE AGED; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH;

EID: 0031914868     PISSN: 03400131     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004200050263     Document Type: Article

References (24)

1. Ganzoni A, Rhomberg F (1965) Haemolytische krise bei Mangel an Glukose-6-Phosphat-dehydrogenase und Bleiintoxikation. Acta Haematol 34: 338-346
2. Saita G, Lussana S (1971) Intossicazione da piombo in portatrice di emazie fabiche. Med Lav 62: 22-26
3. Consiglio delle Comunità' Europee (1982) Direttiva 82/605/ CEE. Sulla protezione dei lavoratori contro i rischi connessi ad un'esposizione al piombo metallico ed ai suoi composti ionici durante il lavoro (prima direttiva particolare ai sensi dell'articolo 8 della direttiva 80/1107/CEE). Gazzetta Ufficiale delle Comunità Europee L247
4. Sugawara E, Nakamura K, Miyake T, Fukumura A, Seki Y (1991) Lipid peroxidation and concentration of glutathione in erythrocytes from workers exposed to lead. Br J Ind Med 48: 239-242
5. Luzzato L, Metha A (1989) Glucose-6-phosphate dehydrogenase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited diseases, 6th edn. McGraw & Hill, New York, p 2237
6. Cherchi P, Carta P, Anni MS, Giacomina C, Alessio L, Casula D (1987) Occupational lead exposure, G6PD deficiency and beta thalassemia trait. Med Lav 78: 75-85
7. Cocco P, Salis S, Anni MS, Cocco ME, Flore C, Ibba A (1995) Effects of short-term occupational exposure to lead on erythrocyte glucose-6-phosphate dehydrogenase activity and serum cholesterol. J Appl Toxicol 15: 375-378
8. Siniscalco M, Bernini L, Latte B, Motulski G (1961) Favism and thalassemia and their relationship to malaria. Nature 190: 1179-1180
9. Cocco PL, Manca P, Dessi S (1987) Preliminary results of a geographic correlation study on G6PD-deficiency and cancer. Toxicol Pathol 15: 106-108
10. Ganczakowski M, Town M, Bowden DK, Vulliamy TJ, Kaneko A, Clegg JB, Weatherall DJ, Luzzatto L (1995) Multiple glucose-6-phosphate dehydrogenase-deficient variants correlate with malaria endemicity in the Vanatu Archipelago (south-western Pacific). Am J Hum Genet 56: 294-301
11. Cocco P, Todde PF, Fornera S, Manca MB, Manca P, Sias AR (1998) Mortality in a cohort of men expressing the erythrocyte glucose-6-phosphate dehydrogenase (G6PD) deficiency. Blood 1998; 91
12. Cocco PL, Carta P, Flore C, Congia P, Manca MB, Saba G, Salis S (1996) Mortality of lead smelter workers with the erythrocyte glucose-6-phosphate dehydrogenase (G6PD) deficient phenotype. Cancer Epidemiol Biomark Prev 5: 223-225
13. Stokinger HE, Scheel LD (1973) Hypersusceptibility and genetic problems in occupational medicine - a consensus report. J Occup Med 15: 564-573
14. Calabrese EJ (1986) Ecogenetics: historical foundation and current status. J Occup Med 28: 1096-1102
15. Reinhardt CF (1978) Chemical hypersusceptibility. J Occup Med 20: 319-322
16. Motulsky A (1968) Comments on "Pharmacogenetics in detection of the hypersusceptible worker". Ann NY Acad Sci 151: 968
17. Stokinger HE, Mountain JT (1963) Test for hypersusceptibility to hemolytic chemicals. Arch Environ Health 6: 57-64
18. Murray RF (1986) Tests of the so-called genetic susceptibility. J Occup Med 28: 1103-1107
19. Long WK, Wilson SW, Frenkel EP (1967) Associations between red cell glucose-6-phosphate dehydrogenase variants and vascular diseases. Am J Hum Genet 19: 35-52
20. Rao KN (1995) The significance of the cholesterol biosynthesis pathway in cell growth and carcinogenesis (review). Anticancer Res 15: 309-314
21. Schwartz AG, Pashko LL, Henderson EE, Tannen RH, Cleasy MP, Abou-Gharbia M, Swern D (1983) Dehydroepiandrosterone: an anti-obesity and anticarcinogenic agent. Commun Res Breast Dis 3: 113-130
22. Wissler RW, Vesselinovitch D, Davis HR (1987) Cellular components of the progressive atherosclerotic process. In: Olsson AG (ed) Atherosclerosis. Biology and clinical science. Churchill Livingstone, Edinburgh, pp 57-68
23. Frankena W (1973) Ethics, 2nd edn. Prentice-Hall, Englewood Cliffs, New Jersey
24. Duffus J (1987) Protection of high risk population groups with genetic variability in response to chemical exposure. Position paper for an informal planning meeting. WHO Regional Office for Europe, Geneva